Inhibition of FAK kinase activity preferentially targets cancer stem cells

Vihren N. Kolev(Verastem (United States)), David T. Weaver(Verastem (United States))

Oncotarget

June 16, 2017

10.18632/oncotarget.18517

Cited by 77

Related Papers

No related papers found

Powered by citation graph analysis